TTC7B is a new prognostic biomarker in head and neck squamous cell carcinoma linked to immune infiltration and ferroptosis
Cancer Medicine · 2023-12 · 12 (24) · 22354-22369
DOI: 10.1002/cam4.6715 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 22.11.2023. Verfasst von Rong He und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Department of Head and Neck Oncology, West China Hospital…. Hauptthemen laut MEDLINE: Ferroptosis, Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
To investigate the expression of TTC7B and its prognostic significance, biological roles, and impact on the immune system in patients with head and neck squamous cell carcinoma (HNSCC). Materials and Methods Clinical and genomic data were obtained from TCGA (The Cancer Genome Atlas), GEO (Gene Expression Omnibus), GEPIA2 (Gene Expression Profiling Interactive Analysis 2.0), and TIMER2.0 (Tumor Immune Estimation Resource 2.0) databases. R software was utilized to process the retrieved data. qPCR and immunohistochemical assays were performed to validate the findings obtained from the databases.
Results
High expression of TTC7B was observed in HNSCC, and this heightened expression is significantly associated with reduced overall survival (OS) in patients, making it an independent risk factor impacting OS. TTC7B is correlated with focal adhesions and cell migration pathways based on functional enrichment analysis. CIBERSORT analysis and TIMER2.0 show a positive link between TTC7B and multiple immune cells, particularly macrophages. Pearson's analysis reveals a significant correlation between TTC7B and ferroptosis‐related genes.
Conclusion
In all, TTC7B could serve as a promising prognostic indicator of HNSCC, and is closely associated with focal adhesions, immune infiltration, and ferroptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
- Guangyuan Hospital of Traditional Chinese Medicine, Guangyuan, China.
ORCID-Profile: Rong He, Longjiang Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
He, R., Zhang, X., Wu, Y., Weng, Z., & Li, L. (2023). TTC7B is a new prognostic biomarker in head and neck squamous cell carcinoma linked to immune infiltration and ferroptosis. Cancer Medicine, 12(24), 22354-22369. https://doi.org/10.1002/cam4.6715
Vancouver
He R, Zhang X, Wu Y, Weng Z, Li L. TTC7B is a new prognostic biomarker in head and neck squamous cell carcinoma linked to immune infiltration and ferroptosis. Cancer Medicine. 2023;12(24):22354-22369. doi:10.1002/cam4.6715
BibTeX
@article{He2023,
author = {He, Rong and Zhang, Xun and Wu, Yongzhi and Weng, Zhijie and Li, Longjiang},
title = {TTC7B is a new prognostic biomarker in head and neck squamous cell carcinoma linked to immune infiltration and ferroptosis},
journal = {Cancer Medicine},
year = {2023},
volume = {12},
number = {24},
pages = {22354--22369},
doi = {10.1002/cam4.6715}
}
EUVIMED